Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results

Table 6 Cox multivariate analysis for PFS

	Progression-free survival (PFS)
	HR	(95% CI)	p value
DCR axitinib	0.171	(0.107–0.272)	< 0.0000001
DCR sunitinib	0.549	(0.308–0.977)	0.041
Heng score
Good prognosis	1		0.174
Poor prognosis	1.909	(0.964–3.779)	0.064
Intermediate	1.249	(0.752–2.073)	0.391
Nephrectomy
Yes	0.572	(0.305–1.072)	0.081
Gender
Male	0.567	(0.378–0.851)	0.006

ISSN: 1479-5876